Login to Your Account

Another local government is considering forcing drugmakers into the waste management business. San Francisco's Board of Supervisors is proposing an ordinance that would make biopharma companies responsible for collecting and disposing of unused prescription and nonprescription drugs used by city residents.

Recognizing that good science can be used for bad purposes or lead to harmful accidents, the National Science Advisory Board for Biosecurity (NSABB) debated the merits of an administration-imposed moratorium on government funding for so-called "gain-of-function" (GOF) research involving influenza, MERS and SARS viruses.

At the end of the day, does it really matter whether the Federal Circuit takes a fresh look at the construction of patent claims or defers to a lower court's interpretation of issues of fact?

More REGULATORY Headlines

Cast Your Vote

Has biotech’s bubble burst?: